K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Philip N. Hawkins
also known as C Hawkins, C P Hawkins, C. Hawkins
The Royal Free Hospital · University College London · Università Cattolica del Sacro Cuore · Boston University
About this author
Works
1,012
Cited by
63,870
h-index
128
i10
440
ORCID ↗
Top papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams, Alejandra González‐Duarte, William O’Riordan, et al.
·
2018
·
New England Journal of Medicine
↗ 2,868
OA
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore, Matthew J. Maurer, Rodney H. Falk, et al.
·
2016
·
Circulation
↗ 1,961
OA
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
Laetitia Agostini, Fabio Martinon, Kimberly Burns, et al.
·
2004
·
Immunity
↗ 1,738
OA
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz, Ray Comenzo, Rodney H. Falk, et al.
·
2005
·
American Journal of Hematology
↗ 1,409
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
David R. Booth, Margaret Sunde, Vittorio Bellotti, et al.
·
1997
·
Nature
↗ 1,042
Systemic amyloidosis
Ashutosh Wechalekar, Julian D. Gillmore, Philip N. Hawkins
·
2015
·
The Lancet
↗ 980
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Alicia M. Maceira, Jayshree Joshi, Sanjay Prasad, et al.
·
2005
·
Circulation
↗ 975
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho, David Adams, Ana Silva, et al.
·
2013
·
New England Journal of Medicine
↗ 959
OA
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
Giovanni Palladini, Angela Dispenzieri, Morie A. Gertz, et al.
·
2012
·
Journal of Clinical Oncology
↗ 952
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Raphaela Goldbach‐Mansky, Natalie Dailey Garnes, Scott Canna, et al.
·
2006
·
New England Journal of Medicine
↗ 898
OA
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Helen J. Lachmann, Isabelle Koné‐Paut, Jasmin Kuemmerle‐Deschner, et al.
·
2009
·
New England Journal of Medicine
↗ 854
OA
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
Philip N. Hawkins, Helen J. Lachmann, Ebun Aganna, et al.
·
2004
·
Arthritis & Rheumatism
↗ 742